Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Assessment of Surgical Treatments in Hemorrhoidal Disease: Real-life Practice and Early Outcome in Terms of Patient-reported Symptoms and Quality of Life

NCT05429060 is registered in ClinicalTrials.gov with Istanbul Medipol University Hospital as lead sponsor.

NCT NCT05429060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05429060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Assessment of Surgical Treatments in Hemorrhoidal Disease: Real-life Practice and Early Outcome in Terms of Patient-reported Symptoms and Quality of Life
Lead sponsor
Istanbul Medipol University Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2022
Completion date
May 31, 2024
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complication of treatment, hemorrhoids, indication, unlabeled, quality of life